GUMDROP : Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol and daily genistein (G-2535) versus placebo in men with early stage prostate cancer undergoing prostatectomy 

Created by Nancy Dawson, last modified on Apr 28, 2013
Description:

Study of Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer

Link:http://clinicaltrials.gov/ct2/show/NCT01325311
Site:Johns Hopkins University
Prinicipal Investigator:Emmanuel Antonarakis, MD